<DOC>
	<DOCNO>NCT01487460</DOCNO>
	<brief_summary>This study ass safety , tolerability , effect TAP311 blood lipid healthy subject patient dyslipidemia . The effect food TAP311 concentration blood effect TAP311 administration simvastatin concentration also assess healthy volunteer .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Pharmacodynamics TAP311 Healthy Subjects Dyslipidemic Patients</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Healthy male female subject age 18 65 year age include , good health determine past medical history , physical examination , electrocardiogram , laboratory test screen . OR untreated dyslipidemic patient . Subjects must weigh least 50 kg participate study , must body mass index ( BMI ) within range 18 36 kg/m2 . Able communicate well investigator , understand comply requirement study . Use investigational drug time enrollment . Active treatment type 1 diabetes type 2 diabetes mellitus . A past medical history ECG abnormality , document cardiac arrhythmia cardiovascular disease . History malignancy organ system , treat untreated , within past 5 year . Pregnant nursing ( lactate ) woman . Smokers . Use prescription drug , herbal supplement and/or overthecounter ( OTC ) medication , dietary supplement . History drug alcohol abuse within 12 month prior dose . Any surgical medical condition , acute unstable chronic disease may , base investigator 's opinion , jeopardize patient case participation study Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>High cholesterol level</keyword>
	<keyword>Hyperlipidemia</keyword>
	<keyword>High-density Lipoprotein</keyword>
	<keyword>Low-density Lipoprotein</keyword>
	<keyword>Simvastatin</keyword>
</DOC>